What You Need to Know About GLP-1 Coverage With the growing popularity of weight-loss medications like Zepbound and Wegovy, many people are asking the same question: Will my health insurance cover these medications in 2026? Theres been some confusion, especially around rumors of changes starting April 1, 2026
May 2024 As of May 1, 2024, the Judicial Panel on Multidistrict Litigation (JPML) reports 87 cases are pending in MDL -3094 IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
Drugs such as Wegovy (semaglutide) and Saxenda (liraglutide) fall into this category of receptor agonists and are often given by subcutaneous injection due to their limited oral bioavailability
Use Weight Watchers AI Body Scanner to see how your body composition is likely changing
WD-reduced hippocampal neurogenesis was normalized by GE2 treatment consistent with effects mediated by GLP-1 receptor agonist treatment in young adult male rodents (9498) and adult and aged female mice (90)
Retatrutide and LDL Cholesterol: How GLP-1 Medications Lower Heart Disease Risk Introduction The world of metabolic medicine has been revolutionized by GLP-1 receptor agonists
